Research & Development


CINV Corp is in the process of developing and curating an exclusive genetics pool.

As part of an R&D effort involving selective breeding of the most formidable and adaptive genetics from around the world. We can offer these on an exclusive basis to our partners.

Many strains can be developed with desired compounds in higher or lower concentrations such as terpenes and some of the common or the rarer but highly efficacious cannabinoids (CBD, THC, THCV, CBDP etc.)


CINV Corp works very closely with the Harare Institute for Technology (HIT), a Zimbabwe-based scientific institute dedicated to technopreneurial leadership. The relevant domains of expertise and collaboration include:

  • Essential oils
  • Fixed oils
  • Drug development and formulations from natural sources.

With a focus on non-communicable and chronic diseases, such as cancer, diabetes, hypertension, arthritis, fibroids and endometriosis.


Acquired licenses to supply the global demand of an effective form of medicinal cannabis to the pharmaceutical industry.